News
-
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
October 14, 2025 -
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
October 13, 2025 -
Aclarion to Present at the LD Micro Main Event XIX
October 9, 2025 -
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
October 7, 2025 -
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
October 1, 2025 -
First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial
September 25, 2025 -
Aclarion Appoints Greg Gould as Chief Financial Officer
September 3, 2025 -
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
August 5, 2025 -
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
July 7, 2025 -
First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial
June 25, 2025